Anti-Aging Therapeutics Volume XV. A4M American Academy. Читать онлайн. Newlib. NEWLIB.NET

Автор: A4M American Academy
Издательство: Ingram
Серия:
Жанр произведения: Медицина
Год издания: 0
isbn: 9781934715154
Скачать книгу
York shows on their Form 990 that they took in $5,242,304 in Total 2009 Income, and they had, that year, Total Assets of $3,017,144. Their Schedule B ANONYMOUS contributions totaled $2,318,652.

      More, CFI claimed that they received, in 2009, in addition to their anonymous contributions, a so-called "Management Fee Income" of $2,458,156. What do you suppose they managed? And who paid them to manage it? Maybe they manage Wikipedia health care articles? How about Search Engine Optimization (SEO) bringing skeptic, including Stephen Barrett's (Quackwatch), articles to the first page of Google?

      Much more - This cabal minimizes and delays innovative medical advancements by lodging anonymous complaints to state licensing boards against cutting-edge practitioners. Their insidious campaign also controls grant monies and research funding, somewhat silencing the voices of innovative medicine in favor of mainstream views. By leveraging control of the media in direct jeopardy of journalistic integrity, this control group seeks to suppress all in medicine that is not fully controlled by the establishment. To permit this level of manipulation and disinformation is wrong and ethically corrupt. The fate of a valuable avenue of medical innovation for the public interest – anti-aging medicine – stands at-risk.”

      A JAMA commentary4 purported to address the legality of Human Growth Hormone (HGH, GH) treatment by physicians for growth hormone deficient (GHD) patients. It is the view of A4M that the commentary contained a number of incorrect, misplaced references and studies, and multiple basic scientific errors, in what A4M views as an apparent attempt to damage the anti-aging medical profession and the physicians practicing solid, evidence-based medical healthcare focused on improving and maintaining patients' quality of life. It is A4M's further opinion that the authors selected self-serving studies, in which they failed to qualify the conclusions in an effort to bolster what A4M believes is a disinformation campaign. It is A4M's opinion, for example, that they incorrectly intermingled internet sales of homeopathic pseudo "GH" sprays, amino acids, and sports nutritional over the counter products in order to inflate their incorrect claims suggesting an illegal diversion of HGH by physicians and pharmacies, implying a black market in FDA approved prescription injectable HGH for hormone replacement treatments by anti-aging physicians where none exists.

      Misrepresentation in Competitive Sports

      As an unfortunate consequence of media confusion and outright deception aiming to deliberately misrepresent anti-aging medical care, the reality of the clinical practice of hormone replacement therapy has become muddled. A recent Sports Illustrated article states5 that: “In the sports world, the term ‘anti-aging’ has often come to signify therapy that uses hormones – usually testosterone and HGH – and … DHEA.” This erroneous definition grossly misrepresents the legal and ethical physiological use of hormones and supplements as being synonymous with the inappropriate use of hormones for sports enhancement. The A4M is squarely opposed to this myopic interpretation of “anti-aging” and urges reference to the official definition of anti-aging medicine as presented above.

      Any use of performance enhancing drugs or hormones banned from professional sports constitutes inappropriate misuse. It is a violation of the A4M Physician Member Code of Ethics to prescribe for the explicit purposes of performance enhancement. The A4M does not endorse or condone the use of any illicit substances for sports cheating. However, the A4M does support the continued availability of such substances to adult patients with objectively assessed hormone deficiencies. Such judicious use of HRT does not equate to a banned drug issue.

      A4M’s physician co-founders Dr. Robert Goldman, MD, PhD, DO, FAASP, Chairman; and Dr. Ronald Klatz, MD, DO, President, are co-authors of Death In the Locker Room (1984), a first-ever expose of the illicit use of anabolic steroids in sports, and Grow Young with HGH (1997), a best-selling book that explored the clinical benefits of judicious and appropriate HGH therapy in deficient adults. Death in the Locker Room is widely regarded as the seminal text on the dangers of anabolic and performance enhancing substances in sports. Death in the Locker Room was the first book to alert the public and the medical community to such issues, and the book subsequently led directly to much of the drug testing, control, and educational programs now in-place across a number of professional sports and on the global level.

      Statute6 21 U.S.C. § 333(e), a provision of the Food, Drug, and Cosmetic Act (FDCA), states, in pertinent part, that "whoever knowingly distributes, or possesses with intent to distribute, human growth hormone for any use in humans other than the treatment of a disease or other recognized medical condition, where such use has been authorized by [FDA] and pursuant to the order of a physician, is guilty of an offense punishable by not more than 5 years in prison." We need to take a critical look at the historical context and legislative intent of a law before we interpret it. The law did not originally address HGH. The 1988 law was written and passed regarding anabolic steroids. The legislative history of the statute shows an intent to focus on steroid trafficking to athletes, particularly adolescent athletes, amid increasing reports of amateur and professional sports doping and concerns about the 1988 Summer Olympics (at which, ironically, Canadian sprinter Ben Johnson's steroid positive ignited a global firestorm).

      Dr. Goldman served as Special Adviser & Lecturer to the US Drug Enforcement Agency (DEA) Demand Reduction Education Programs nationally, as well as to the US Olympic Committee, spearheading the design of drug policy and testing procedures. In his activities with the DEA, Dr. Goldman was directly involved in an advisory capacity with the process that led to the creation of the Anabolic Steroid Control Act of 1990. “The Anabolic Steroid Control Act was never intended to restrict practicing physicians involved in the clinical treatment of hormone deficiency syndromes,” comments7 Dr. Goldman, who explains that: “Rather, this law was specifically directed to prevent the trafficking of anabolic steroids to athletes.”

      The Anabolic Steroid Control Act of 1990 lifted steroids out of the FDCA and into the Controlled Substances Act. Congress was presented with the option of making HGH into a controlled substance, too. However, following expert medical testimony that HGH lacks the adverse psychological and physical effects of steroids, Congress chose not to take such a drastic approach to HGH.8,9 Instead, Congress took the lesser approach of inserting HGH, to replace steroids, in the FDCA law that was written to stop trafficking to cheating athletes. In fact, HGH was inserted as an afterthought, with no penalties mentioned, as editorial comment; there was no intention to criminalize its judicious use in the clinical setting by trained physicians. The focus of lawmakers and Congress has always been to address non-medical use, i.e., improper use by competitive elite athletes, sports people and teenagers. It is A4M's view that the JAMA commentary4 fails to understand or appreciate such legislative history and legislative purpose. A4M is advised that one of the authors of the JAMA commentary stated to United Press International (UPI) in reference to the statute, "They basically put in language that made it crystal clear that it is illegal to use growth hormone as an anti-aging intervention".10 This is a very odd and A4M believes, an incorrect statement, considering the fact that when the law was written, there were no anti-aging doctors or profession in existence. In fact, the anti-aging medical profession did not even exist until five years after the 1988 statute was enacted. The concept of HGH s an anti-aging drug did not exist until the problem of Rudman’s study.12

      The Anabolic Steroid Control Act never intended to infringe upon physician freedoms to prescribe hormone therapy when clinically appropriate. It was specifically intended to prevent steroid trafficking in professional sports. Whereas education should have been a primary goal in implementing the Anabolic Steroid Control Act, instead an enforcement environment that granted limitless power unto itself was created. A multi-million dollar industry of drug testing was born and subsequently flourishes.

      DISINFORMATION CAMPAIGN

      History is replete with examples of medical pioneers whose innovations and foresight were trivialized, ignored, challenged, or violently opposed by the establishment, only to ultimately become accepted by society at-large. Leopold Auenbrugger was ridiculed for percussing and auscultating his patients' chests; Ignaz Semmelweiss' recommendation for doctors to wash their hands before each patient landed him in a mental asylum; and more recently, cardiologists denied